BRIM Biotechnology, Inc. (TPE:6885)

Taiwan · Delayed Price · Currency is TWD

20.70

0.00 (0.00%)

Jul 30, 2026, 12:16 PM CST

BRIM Biotechnology Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	8.21	5.49	0.33	0.09	0.53	0.36
Revenue Growth	1796.77%	1548.65%	270.00%	-82.89%	46.11%	-99.60%
Gross Profit	0.92	1.25	0.02	0.09	0.53	0.36
Operating Income	-457.24	-452.97	-344.79	-694.13	-218.33	-93.22
Net Income	-431.89	-436.45	-315.47	-688.02	-274.28	-105.45
Earnings Per Share	-3.29	-3.32	-2.70	-6.84	-3.85	-1.78
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Quanfu	4.12	0.33
Pepsico and Its Subsidiaries	1.37	-
Total	5.49	0.33

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,068	1,158	1,849	1,696	837.99	423.59
Total Debt	13.32	15.96	7.78	3.59	6.44	3.16
Net Cash (Debt)	1,054	1,142	1,841	1,692	831.55	420.42
Net Cash Growth	-40.97%	-37.94%	8.80%	103.48%	97.79%	157.57%
Net Cash Per Share	8.03	8.69	15.78	16.83	11.66	7.09

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-358.11	-329.17	-279.24	-596.89	-171.87	-112.57
Capital Expenditures	-2.51	-0.8	-2.9	-2.26	-1.11	-0.78
Free Cash Flow	-360.62	-329.97	-282.14	-599.15	-172.98	-113.35
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	11.20%	22.77%	6.61%	100.00%	100.00%	100.00%
Operating Margin	-5567.30%	-8250.89%	-103539.04%	-771250.00%	-41506.84%	-25893.06%
Pretax Margin	-5564.50%	-8213.30%	-94735.74%	-764468.89%	-52143.92%	-29291.39%
Profit Margin	-5258.58%	-7949.94%	-94735.74%	-764468.89%	-52143.92%	-29291.39%
FCF Margin	-4390.88%	-6010.38%	-84726.73%	-665723.33%	-32885.74%	-31485.83%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	335.26	721.88	12216.14	38520.36	6763.57	-